Donate
Donate

Blog Home

20th Anniversary

Rally-Funded Discoveries

Advocacy

Childhood Cancer

What Is

Dean’s Reflections

Fundraising & Events

Community Partners
September

Press Room

News

Rally Stories

Kids
Teens
Families
Survivors

Research

Grant Awards
Rally Researchers
Success Stories

Rally Researchers

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

$

Sign up for our emails!

Fill out my online form.

< Blog Home

Rally Researchers

$3.3 Million of Good News

by | Apr 1, 2020

Could you use some good news? We have some good news. Actually, we have some GREAT news! Rally Foundation for Childhood Cancer Research just awarded $3.3 million in childhood cancer research grants. This is our largest single-year commitment and brings Rally Foundation’s awarded total to $20 million to find better treatments with fewer long-term side effects and, ultimately, cures. Thank you to our supporters who made these grants possible. Thank you to the Rally Medical Advisory Board who...

read more
Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

Newly Elected COG Chair Dr. Douglas Hawkins Shares His ‘North Star’

by | Mar 22, 2020

Rally was pleased when it was announced that the newly elected chair of the Children’s Oncology Group (COG) was going to be Dr. Doug Hawkins, a Rally-funded Researcher who has served for the past nine years on the Rally Medical Advisory Board and received funding for early phase trials and biologic specimen collection at Seattle Children’s Hospital (SCH). Dr. Hawkins is also the Division Chief of Hematology-Oncology and the Associate Director of the Center for Clinical and Translational...

read more
Research for Recurrent Brain Tumors Shows Promising Preliminary Results

Research for Recurrent Brain Tumors Shows Promising Preliminary Results

by | May 9, 2019

As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the common cold sore virus, otherwise known as herpes simplex or G207. Thanks to Rally Foundation funding, Dr. Friedman and his...

read more

$

Sign up for our emails!

Fill out my online form.